Skip to content
value.today

Precision Dermatology, Inc.

🇺🇸 Cumberland, Rhode Island, USAPharmaceuticalsFounded 2010
Total raised
$74 M
2 rounds on record
Latest round
$55 M
Apr 2012
First round on record
Nov 2010
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Precision Dermatology, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2012$55 MNo. 2$50 to $250 million

Precision Dermatology, Inc.: Raise no. 2, Apr 2012

Investors in this round

0 investors had bought by the notice of Nov 13, 2012: 0 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$55 M of $58 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeffrey N. Nugent · Executive Officer, Director
  • Steven N. Tannenbaum · Executive Officer
  • Adele N. Oliva · Director
  • Immanuel N. Thangaraj · Director
  • Michael N. Heffernan · Director
  • Patrick N. Heron · Director
  • William N. Crouse · Director
  • William N. Robb · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Steven N. Tannenbaum, Secretary. Source: SEC Form D and 1 amendment, newest notice filed Nov 13, 2012. Read the notice at the SEC.

equitySEC
Nov 2010$19 MNo. 1$10 to $50 million

Precision Dermatology, Inc.: Raise no. 1, Nov 2010

Investors in this round

10 investors had bought by the notice of Nov 24, 2010: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$19 M of $20 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeffrey M. Nugent · Executive Officer, Director
  • Steven N. Tannenbaum · Executive Officer
  • Immanuel M. Thangaraj · Director
  • Matthew M. Strobeck · Director
  • Michael M. Heffernan · Director
  • Patrick M. Fortune · Director
  • Patrick M. Heron · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Steven N. Tannenbaum, Secretary and Treasurer. Source: SEC Form D, newest notice filed Nov 24, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Precision Dermatology, Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2012).

    SEC Form D · Nov 2012

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Nov 2012

That is all the official record says: Precision Dermatology, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Precision Dermatology, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 10 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Precision Dermatology, Inc.
NameRoleNamed in
Jeffrey N. NugentExecutive officerNov 2012
Steven N. TannenbaumExecutive officerNov 2012
Jeffrey M. NugentExecutive officerNov 2010
Adele N. OlivaDirectorNov 2012
Immanuel N. ThangarajDirectorNov 2012
Jeffrey N. NugentDirectorNov 2012
Michael N. HeffernanDirectorNov 2012
Patrick N. HeronDirectorNov 2012
William N. CrouseDirectorNov 2012
William N. RobbDirectorNov 2012
Immanuel J. ThangarajDirectorMay 2012
Michael J. HeffernanDirectorMay 2012
Patrick J. FortuneDirectorMay 2012
Patrick J. HeronDirectorMay 2012
Immanuel M. ThangarajDirectorNov 2010
Jeffrey M. NugentDirectorNov 2010
Matthew M. StrobeckDirectorNov 2010
Michael M. HeffernanDirectorNov 2010
Patrick M. FortuneDirectorNov 2010
Patrick M. HeronDirectorNov 2010